average a1c reduction glp-1 treatment GLP-1s Lead to Greater Weight Loss and Improvement Than Metformin in Patients with PCOS Eli Lilly's oral GLP-1 for
Description
A 2025 study found patients who stopped early (often due to side effects or cost) lost only 3.6% of their body weightfar from the transformative results advertised
JeanGilles encourages patients to monitor how they feel during the first few weeks and to reach out with questions no matter how small
Indication 18.6.7
These findings are consistent with those of previous studies investigating semaglutide [25] or other GLP-1 agonists [36,37,38] in this population
Are there safety concerns with unsupervised GLP-1 use if medications became OTC
